Metformin vs Insulin in the Management of Gestational Diabetes: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Nowadays, there have been increasing studies comparing metformin with insulin. But the use of metformin in pregnant women is still controversial, therefore, we aim to examine the efficiency and safety of metformin by conducting a meta-analysis of randomized controlled trials (RCTs) comparing the effects of metformin with insulin on glycemic control, maternal and neonatal outcomes in gestational diabetes mellitus (GDM). METHODS: We used the key words "gestational diabetes" in combination with "metformin" and searched the databases including Pubmed, the Cochrane Library, Web of knowledge, and Clinical Trial Registries. A random-effects model was used to compute the summary risk estimates. RESULTS: Meta-analysis of 5 RCTs involving 1270 participants detected that average weight gains after enrollment were much lower in the metformin group (n = 1006, P = 0.003, SMD = -0.47, 95%CI [-0.77 to -0.16]); average gestational ages at delivery were significantly lower in the metformin group (n = 1270, P = 0.02, SMD = -0.14, 95%CI [-0.25 to -0.03]); incidence of preterm birth was significantly more in metformin group (n = 1110, P = 0.01, OR = 1.74, 95%CI [1.13 to 2.68]); the incidence of pregnancy induced hypertension was significantly less in the metformin group (n = 1110, P = 0.02, OR = 0.52, 95%CI [0.30 to 0.90]). The fasting blood sugar levels of OGTT were significantly lower in the metformin only group than in the supplemental insulin group (n = 478, P = 0.0006, SMD = -0.83, 95%CI [-1.31 to -0.36]). CONCLUSIONS: Metformin is comparable with insulin in glycemic control and neonatal outcomes. It might be more suitable for women with mild GDM. This meta-analysis also provides some significant benefits and risks of the use of metformin in GDM and help to inform further development of management guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The finding that metformin decreased the frequency of preeclampsia was consistent with the findings reported in a meta-analysis by Gui et al.(75) and Feng and Yang(76).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [75]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While individual RCTs support limited efficacy of metformin (73,74) and glyburide (75) in reducing glucose levels for the treatment of GDM, these agents are not recommended as the first-line treatment for GDM because they are known to cross the placenta and data on long-term safety for offspring is of some concern (35).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [74]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Gui et al.(75) published a systematic review and meta-analysis in which metformin was shown to be superior to insulin in reducing maternal weight gain during pregnancy as well as in the frequency of gestational hypertension (Figure 5a,); however, metformin did not change the frequency of large-for-gestational-age (LGA) or small-for-gestational-age (SGA) fetuses or of hypoglycemia and preeclampsia(”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [75]
In the citing paper
“Gui et al.(75) published a systematic review and meta-analysis in which metformin was shown to be superior to insulin in reducing maternal weight gain during pregnancy as well as in the frequency of gestational hypertension (Figure 5a,); however, metformin did not change the frequency of large-for-gestational-age (LGA) or small-for-gestational-age (SGA) fetuses or of hypoglycemia and preeclampsia(”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [75]
In the citing paper
“however, metformin did not change the frequency of large-for-gestational-age (LGA) or small-for-gestational-age (SGA) fetuses or of hypoglycemia and preeclampsia(75).”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [75]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
International Association of Diabetes and Pregnancy Study Groups Consensus Panel (2010) · Diabetes Care · doi:10.2337/dc09-1848 · Cited by 5,390 · cited 1×
“Furthermore, the influence of the intrauterine hyperglycemia environment might go with the children in later life [3], [9].”
BackgroundEffect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes
Crowther, C. A., Hiller, J. E., Moss, J. R., McPhee, A. J., Jeffries, W. S., & Robinson, J. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042973 · Cited by 3,159
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Metzger, B. E., Gabbe, S. G., Persson, B., Lowe, L. P., Dyer, A. R., Oats, J. J. N., & Buchanan, T. A. (2010) · Diabetes Care · doi:10.2337/dc10-0719 · Cited by 1,888
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720 · cited 1×
“The possible explanation might be that metformin has complex properties on endothelial functions and reactive oxygen species production [34], so as to reduce the endothelial activation and maternal inflammatory response of insulin resistance.”
BackgroundMetformin versus insulin for the treatment of gestational diabetes
Rowan, J. A., Hague, W. M., Gao, W., Battin, M. R., & Moore, M. P. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707193 · Cited by 1,291 · cited 5×
“In this meta-analysis, the incidence of requiring additional insulin to achieve euglycemia was especially high in the study of Rowan [27] (46.”
BackgroundMethodResultInfluentialKirpichnikov, D., McFarlane, S. I., & Sowers, J. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00009 · Cited by 1,084 · cited 1×
“Metformin reduces hyperglycemia by suppressing hepatic glucose output (hepatic gluconeogenesis), increasing insulin sensitivity and enhancing peripheral glucose uptake [30].”
Background
Cited by
Items 101–200 of 220
Maternal and In Utero Determinants of Type 2 Diabetes Risk in the Young
Bruce, K. D. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0446-0 · Cited by 16
Non-pharmacological management of gestational diabetes: The role of myo-inositol
Guardo, F. D., Currò, J. M., Valenti, G., Rossetti, P., Di Gregorio, L. M., Conway, F., Chiofalo, B., Garzon, S., Bruni, S., & Rizzo, G. (2020) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2019-0111 · Cited by 14
Pharmacological Management of Gestational Diabetes Mellitus
Bergel, R., Hadar, E., Toledano, Y., & Hod, M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0802-y · Cited by 19
Pineda-Cortel, M. R., Manalo, M. E. M., Canivel, R. R. C., Matias, R. S., Dizon, A. J. B., Bacani, M. N. S., & Dalmacio, J. S. B. (2018) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000799 · Cited by 15
“Another study where the use of metformin was compared with insulin therapy, their meta-analysis resulted to metformin being comparable with the effects of insulin and with less adverse neonatal outcomes and more benefits to the mother such as inhibition of abnormal maternal weight gain [21].”
BackgroundResultResearch progress of metformin in gestational diabetes mellitus: a narrative review
Ouyang, H., Al-Mureish, A., & Wu, N. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-192 · Cited by 19
“Pregnant women gain weight Zhang et al. (72). found that women with GDM treated with metformin had significantly lower BMI, body mass Table 2 (continued) Author/year/region Research type Experimental group/ Control group Number of experimental/ control group (GDM) Adverse mother outcome (metformin) (decrease/increase/…”
BackgroundInfluentialManagement of diabetes and pregnancy – When to start and what pharmacological agent to choose?
Hiersch, L., & Yogev, Y. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.04.020 · Cited by 16
Yarandi, R. B., Amiri, M., Tehrani, F. R., & Behboudi‐Gandevani, S. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13603 · Cited by 17
Inpatient Glycemic Management of the Pregnant Patient
Yeh, T., Yeung, M., & Curanaj, F. A. M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1045-x · Cited by 13
Screening and management of major endocrinopathies during pregnancy: an update
Paschou, S. Α., Bletsa, E., Papazisi, M., Mili, N., Kanouta, F., Kassi, G., Ψαλτοπούλου, Θ., Goulis, D. G., & Lambrinoudaki, I. V. (2022) · Endocrine · doi:10.1007/s12020-022-03237-y · Cited by 14
“Furthermore, metformin offers inadequate glycemic control for the treatment of GDM compared with insulin [24, 25].”
BackgroundRajwar, E., Pundir, P., Parsekar, S. S., Anupama, D. S., D’Souza, S. R. B., Nayak, B. S., Noronha, J. A., D’Souza, P., & Oliver, S. R. (2023) · Health Policy and Planning · doi:10.1093/heapol/czad008 · Cited by 20
Screening, Diagnosis and Management of Gestational Diabetes Mellitus
Bhavadharini, B., Ram, U., & Mohan, V. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-023-00376-7 · Cited by 12
A Review on the Use of Metformin in Pregnancy and Its Associated Fetal Outcomes
Verma, V., & Mehendale, A. M. (2022) · Cureus · doi:10.7759/cureus.30039 · Cited by 12
“Five randomized controlled trials on this subject were conducted, and the meta-analysis concluded that metformin helps lower the mother's weight gain throughout pregnancy and reduces the occurrence of pregnancy-induced hypertension (or pre-eclampsia) [24].”
BackgroundBusso, D., González-Muñoz, A., Santander, N. G., Saavedra, F., Quíroz, A., Rivera, K., González‐Pérez, J. A., Olmos, P. R., Marette, A., Bazinet, L., et al. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300047 · Cited by 13
Zhen, X. M., Li, X., & Chen, C. (2018) · Obesity Medicine · doi:10.1016/j.obmed.2018.08.001 · Cited by 12
Metformin Indications, Dosage, Adverse Reactions, and Contraindications
Stoica, R. A., Ștefan, D. S., Rizzo, M., Suceveanu, A., Suceveanu, A. P., Serafinceanu, C., & Stoian, A. P. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.88675 · Cited by 17
“Some controlled randomized trials are proving limited efficacy of metformin during pregnancy [30, 31].”
BackgroundGică, N., & Huluță, I. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002793 · Cited by 11
Gerede, A., Domali, E., Chatzakis, C., Margioula‐Siarkou, C., Petousis, S., Stavros, S., Nikolettos, K., Gouveri, E., Sotiriou, S., Tsikouras, P. N., et al. (2025) · Life · doi:10.3390/life15010130 · Cited by 13
Use of antidiabetic agents in the treatment of gestational diabetes mellitus in G ermany, 2008–2012
Heilmaier, C., Thielscher, C., Ziller, M., Altmann, V., & Kostev, K. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12384 · Cited by 10
Szukiewicz, D., Szewczyk, G., Pyźlak, M., Stangret, A., Bachanek, M., Trojanowski, S., Alkhalayla, H., & Wejman, J. (2018) · Inflammation · doi:10.1007/s10753-018-0867-7 · Cited by 9
Gestational diabetes: an onomastic opportunity
Kalra, S., Baruah, M. P., Gupta, Y., & Kalra, B. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70104-9 · Cited by 8
Insulin Therapy and Diabetic Pregnancy
Napoli, A. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001095 · Cited by 9
Targeting the vascular dysfunction: Potential treatments for preeclampsia
Marshall, S. A., Langston‐Cox, A., Parry, L. J., & Wallace, E. M. (2018) · Microcirculation · doi:10.1111/micc.12522 · Cited by 8
GESTATIONAL DIABETES MELLITUS;
Hashmi, K. S., Akhtar, T., Batool, S., & Saleem, K. (2019) · The Professional Medical Journal · doi:10.29309/tpmj/2019.26.01.2593 · Cited by 8
The Role of Metformin in Treating Preeclampsia
Cheng, D., Zhou, X., & Xu, X. (2021) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000086 · Cited by 8
“made a systematic review and meta-analysis, demonstrating that metformin was a better choice than insulin for reducing the incidence of PIH.(22)”
BackgroundInfluentialPagotto, V., Posadas Martínez, M. L., Salzberg, S., & Pochettino, P. A. (2022) · Revista de la Facultad de Ciencias Médicas de Córdoba · doi:10.31053/1853.0605.v79.n3.36734 · Cited by 7
Zade, S. R., Khasbage, S. U., Mishra, A., & Mehani, R. (2025) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2025.101442 · Cited by 9
Suboptimally Controlled Diabetes in Pregnancy: A Review to Guide Antepartum and Delivery Management
Cate, J. J. M., Bloom, E. A., Chu, A., Bauer, S., Kuller, J. A., & Dotters-Katz, S. K. (2024) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000001270 · Cited by 7
“53,54 In a meta-analysis by Farrar et al comparing insulin, metformin, and glyburide, metformin was associated with lowest risk of common adverse neonatal outcomes such as hypoglycemia, macrosomia, LGA, and preterm birth risk, as well as maternal preeclampsia.”
BackgroundGestational Diabetes Mellitus: Challenges in Diagnosis and Management
Roy, P., Agrawal, P. K., Garg, R., Gautam, A., Hokabaj, S., & Goel, H. (2018) · Journal of South Asian Federation of Obstetrics and Gynaecology · doi:10.5005/jp-journals-10006-1558 · Cited by 7
Masood, S. N., Baqai, S. M., Naheed, F., Masood, Y., Sikandar, R., Chaudhri, R., Yasmin, H., & Korejo, R. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_88_20 · Cited by 12
Virtanen, A., Huttala, O., Tihtonen, K. M. H., Toimela, T., Heinonen, T., Laivuori, H. M., & Uotila, J. T. (2020) · Pregnancy Hypertension · doi:10.1016/j.preghy.2020.06.008 · Cited by 7
Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
Baptista, M., Lorigo, M., & Cairrão, E. (2022) · BioMedInformatics · doi:10.3390/biomedinformatics2020014 · Cited by 6
Oral hypoglycemic agents: do the ends justify the means?
Langer, O. (2015) · Maternal Health Neonatology and Perinatology · doi:10.1186/s40748-015-0021-6 · Cited by 5
“Gui J, Liu Q, Feng L. Metformin vs insulin in the management of gestational diabetes: a meta-analysis.”
BackgroundThe Prevention of Gestational Diabetes
Giugliano, E., & Caserta, B. G. D. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000286 · Cited by 6
Management of Gestational Diabetes Mellitus
Yu, S. H. (2017) · Hanyang Medical Reviews · doi:10.7599/hmr.2017.37.1.30 · Cited by 5
“In metformin-treated studies, equivalent pregnancy outcomes were shown, such as decreased weight gain and maternal hypoglycemia [21].”
van Hoorn, E. G. M., Rademaker, D., van der Wel, A. W. T., DeVries, J. H., Franx, A., van Rijn, B. B., Kooy, A., Siegelaar, S. E., Roseboom, T. J., Ozanne, S. E., et al. (2023) · Diabetic Medicine · doi:10.1111/dme.15243 · Cited by 6
Metformin Exposure and Risk of Hypertensive Disorders of Pregnancy in Patients with Type 2 Diabetes
Racine, J. L., Adams, J. H., Antony, K. M., Hoppe, K. K., Iruretagoyena, J. I., Stewart, K. S., Eddy, A., & Rhoades, J. S. (2021) · American Journal of Perinatology · doi:10.1055/s-0041-1728821 · Cited by 5
Sivadasan, S., Subramanian, M., & Aiyalu, R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99815 · Cited by 5
“Results of systematic review and meta-analysis had shown that metformin is better than insulin in reducing, maternal weight gain during pregnancy and the frequency of pregnancy induced hypertension, with no changes in the frequency of hypoglycemia and pre-eclampsia [45].”
BackgroundQuadir, H. (2021) · Cureus · doi:10.7759/cureus.18818 · Cited by 6
“Although metformin was concluded to have a significant impact on reducing pregnancy-induced hypertension (PIH) versus insulin, it showed no change in preeclampsia [11,12].”
BackgroundBenhalima, K., Mathiesen, E. R., Paldanius, P. M., & Mathieu, C. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13386 · Cited by 4
“hypoglycaemic agents, such as metformin and glibenclamide, during pregnancy mostly concerns women with gestational diabetes.(5,6) In addition, there is a paucity of long-term follow-up data on children exposed to these agents in utero.”
BackgroundAburisheh, K. H., Barhoush, M. M., Alahmari, A. N., Altasan, Z. A., & Alharthi, M. H. (2024) · Biomedicines · doi:10.3390/biomedicines12092040 · Cited by 7
“A meta-analysis of five randomized studies comprising 1270 patients with GDM was consistent with our findings, as it concluded that metformin causes similar neonatal complications to insulin [25].”
ResultTo Compare Metformin Vs Insulin in Gestational Diabetes in Terms of Neonatal Hypoglycemia
Mir, S., Saleem, R., Saghir, F., Mir, S. Z., Iqbal, A., & Manzoor, A. (2021) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2115112928 · Cited by 5
Medications for Managing Preexisting and Gestational Diabetes in Pregnancy
Rickert, M. C., Caughey, A. B., & Valent, A. M. (2023) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2022.10.007 · Cited by 5
Appajigol, J., & Bellary, S. (2015) · International Journal of Community Medicine and Public Health · doi:10.5455/2394-6040.ijcmph20150516 · Cited by 4
“7% (8) obstetricians knew the approximate prevalence of GDM.”
BackgroundChristian, S. J., Boama, V., Satti, H., Ramawat, J., Elhadd, T. A., Ashawesh, K., Dukhan, K., & Beer, S. F. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3540-1 · Cited by 7
Ping, F., Deng, M., Zhai, X., Song, Y., & Xiao, X. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0618-2 · Cited by 5
Diabetes mellitus in pregnancy
Motha, M. B. C., & Dias, T. (2015) · Sri Lanka Journal of Obstetrics and Gynaecology · doi:10.4038/sljog.v37i2.7745 · Cited by 5
A Clinical Insight into Gestational Diabetes
Hh, S., Mahmood, T., Siddiqui, M. H., Bagga, P., Ahsan, F., & Shamim, A. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.85892 · Cited by 3
D’Souza, A., Abdullahi, H., Badri, F., & Ibrahim, I. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-025-07869-6 · Cited by 5
“In contrast, some studies have reported that metformin use is associated with less gestational hypertension [34, 35] and preeclampsia [36] compared to insulin.”
Najafian, M., Barati, M., Masihi, S., & Fardipor, A. (2016) · Global Journal of Health Science · doi:10.5539/gjhs.v9n4p272 · Cited by 3
Daud, N. A. A., Mohiuddin, S. G., Ong, Y. P., Yusof, F. A. M., Yusoff, F., Harun, S. N., & Ghadzi, S. M. S. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_542_20 · Cited by 3
Pandey, A. K., Naik, B., Uday, R., & Shivaprasad, C. (2024) · Cureus · doi:10.7759/cureus.61849 · Cited by 5
“A meta-analysis on metformin vs insulin in the management of GDM by Feng et al. concluded that metformin was comparable to insulin in glycemic control and neonatal outcome [10].”
MethodKumar, R., LOWE, J. M., Thompson-Hutchison, F., Steinberg, D. J., Shah, B. R., Lipscombe, L. L., & Halperin, I. J. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.06.005 · Cited by 3
Diagnosis and Medical Management of Gestational Diabetes
Kim, S. (2015) · Journal of Korean Diabetes · doi:10.4093/jkd.2015.16.3.174 · Cited by 3
“에 메트포르민을 사용한 연구에서 동등한 임신 성적을 보 였고 체중증가가 감소했으며 산모의 저혈당도 적었다고 보 고되었다[31].”
Antidiabétiques oraux et grossesse
Sénat, M. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30120-7 · Cited by 7
Treatment options of Adolescent Gestational Diabetes: Effect on Outcome
Jasim, S. K., Al-Momen, H. H., & Wahbi, M. A. (2021) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.37.4.3966 · Cited by 7
7. Management of hyperglycemia during pregnancy
(2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30015-1 · Cited by 3
Diagnosis and management of gestational diabetes mellitus
Oh, T. J. (2023) · Journal of Korean Medical Association · doi:10.5124/jkma.2023.66.7.414 · Cited by 3
Metformina y diabetes gestacional
Martín-Herrasti, J. M. S., Alcázar-Álvarez, L. S., Serrano-Berrones, M. Á., Tirado-Chávez, J., & Castro-Herrera, G. A. (2014) · Revista de especialidades m�dico-quir�rgicas · Cited by 8
Metformin as a Safe Option to Insulin in Gestational Diabetes Mellitus: a Retrospective Study
Rodrigues, I. M., Figueiredo, A., Pereira, N., Amaral, N. Y. B., Pratas, S., Valadas, C., Dias, E., & Veríssimo, C. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00229-9 · Cited by 5
van Hoorn, E. G. M., van Dijk, P. R., Prins, J. R., Lutgers, H. L., Hoogenberg, K., Erwich, J. J., & Kooy, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-056282 · Cited by 4
Busarira, M. O., Getlawi, O. H., Hawda, S. M., Falgosh, S. A., & Peela, J. R. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_168_21 · Cited by 3
“[22] However, these two analyses are older and with the gradual development of research, there is evidence suggesting that metformin does not cause an increase in the risk of preterm delivery.”
Arterial stiffness in gestational diabetes: Latest insights
Anness, A. R., Khalil, A. A., & Mousa, H. (2025) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2025.102587 · Cited by 2
Targeting of NF‐κB/NLRP3 Axis in Gestational Diabetes Mellitus
Khatap, A. M. F., Al-Kuraishy, H. M., Al-Maiahy, T. J., Al-Gareeb, A. I., Eliwa, D., Saleh, A. M., Abdel‐Aziz, H. R., & Batiha, G. E. (2025) · American Journal of Reproductive Immunology · doi:10.1111/aji.70188 · Cited by 2
“Furthermore, there is a comparable efficacy of insulin and metformin in the management of GDM [59].”
The Challenge to Deliver Cost Effective Care for Patients with Gestational Diabetes Mellitus
Quinlivan, J. (2014) · Reproductive System & Sexual Disorders · doi:10.4172/2161-038x.1000144 · Cited by 2
“However, patients with high blood sugar levels usually benefit from insulin or combined therapy [13].”
BackgroundAziz, K. M. A. (2017) · General Medicine Open Access · doi:10.4172/2327-5146.1000e113 · Cited by 2
“Similarly, other oral medications also have not been studied well and lack long term safety data (RCT) [5-8].”
BackgroundNICE 's latest guidelines on diabetes in pregnancy: getting the balance right
Holt, H. (2015) · Practical Diabetes · doi:10.1002/pdi.1930 · Cited by 2
Rol de la metformina en el tratamiento de la diabetes mellitus gestacional: situación actual
Miranda, P. J. P., Palacios, L. P. T., Cueva, J. L. C., Avilés, G. A. H., Maldonado, E. I. B., Moya, J. I. E., Moya, J. R. E., Acosta, J. M. S., & Lozada, E. M. V. (2019) · Archivos Venezolanos de Farmacología y Terapéutica · Cited by 10
Tratamiento actual de la diabetes gestacional
Salat, D., & Aguilera, C. (2015) · Medicina Clínica · doi:10.1016/j.medcli.2015.04.014 · Cited by 6
Jakiel, G., Bijok, J., & Bińkowska, M. (2014) · Ginekologia Polska · doi:10.17772/gp/1765 · Cited by 2
Use of Antidiabetic, Antihypertensive, and Psychotropic Drugs in Pregnancy
Fasanella, D. R., Luttrell, S. E., Tejada, F. R., Ngokobi, H., & Ayuk-Tabe, M. (2018) · Side effects of drugs annual · doi:10.1016/bs.seda.2018.07.005 · Cited by 4
Khan, M. K., & Baig, R. U. (2022) · Journal of Clinical and Nursing Research · doi:10.26689/jcnr.v6i4.4164 · Cited by 5
“Human insulin cannot cross placental barrier, and it is considered safe in pregnancy as no such reports of fetal complications have been registered yet ([16]).”
BackgroundInfluentialOral antidiabetic agents in gestational diabetes: a narrative review of current evidence
Singh, A. K., & Singh, R. (2014) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2015.982090 · Cited by 2
“(2014), involving only RCTs, suggested a significantly better maternal outcome (weight gain, pregnancy-induced hypertension and preeclampsia) in metformin-treated mothers compared to insulin [64,65].”
BackgroundMethodProvider-based initiation and management of pharmacologic therapy for gestational diabetes mellitus
Harrison, R. K., Johnson, C., Cruz, M., Wong, A., Davitt, C. C., & Palatnik, A. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1852210 · Cited by 2
“Oral antidiabetic medications such as glyburide and metformin can be used as a second-line and have also demonstrated clinical efficacy [11,12].”
BackgroundMetformin Versus Insulin for Pregnancy Outcomes in Gestational Diabetes: a Meta-Analysis
Wang, F. (2020) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2020.10.001478 · Cited by 2
“But several previous publications noted that metformin led to premature birth [47,48].”
BackgroundResultManzur-Jattin, F., Corrales-Santander, H. R., Pacheco-Ayos, C., Carbonell-Riquett, L. F., González-Oñate, J., Ardila-Saenz, A., Manotas-Molina, A., Manotas-Molina, L., & Pérez-Llerena, L. (2020) · Revista chilena de obstetricia y ginecología · doi:10.4067/s0717-75262020000400408 · Cited by 4
Elevated Serum Ferritin Levels in Gestational Diabetes Mellitus (GDM) at a Tertiary Care Hospital
Jaan, M., Saeed, A., Munwar, A., Yasmin, S., Zaman, N., & Zafar, A. (2023) · Pakistan Journal of Medical and Health Sciences · doi:10.53350/pjmhs2023172637 · Cited by 1
Onah, P. O., Idoko, C. C., & Abdulateef, S. (2023) · International Journal of Integrated Health Sciences · doi:10.15850/ijihs.v11n1.2840 · Cited by 1
Review on pharmacological therapies for management of gestational diabetes
Shabnam, A., & Safia, B. (2023) · International Journal of Pharmaceutical Sciences and Developmental Research · doi:10.17352/ijpsdr.000047 · Cited by 2
Challenges in Conducting Clinical Trials for Preeclampsia
Bank, T. C., Kline, D., & Costantine, M. M. (2023) · Current Hypertension Reports · doi:10.1007/s11906-023-01276-y · Cited by 2
“…risk of pregnancy-induced hypertension with the use of metformin (OR 0.52, 95% CI 0.30 to 0.90, p = 0.02), although preec-lampsia risk was similar between those receiving metformin or placebo, suggesting that this difference was primarily driven by a reduction in gestational hypertension [84].”
InfluentialA Metformina como opção terapêutica no diabetes mellitus gestacional: uma revisão de literatura
Klingelfus, A., Seabra, B. H. M., Techio, M. H. S., & Cruz, J. R. (2024) · Brazilian Journal of Development · doi:10.34117/bjdv10n8-029 · Cited by 1
Hiware, S. K., Mahatme, M., Kodape, R. K., & Chati, A. A. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20252338 · Cited by 2
Eficácia da metformina no tratamento do diabetes mellitus gestacional
Sales, W. B., Silva, M. R. E., do Amaral, A. R., Ferreira, B. D. S., Silva, J. C., & Bertini, A. M. (2016) · Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research · doi:10.21722/rbps.v17i3.14510 · Cited by 18
Rommy, Karinaningrum, A. D., Luthfiananda, B., Aniq, L., Evelina, L. S., & Fauzi, R. (2022) · Indonesian Journal of Pharmacology and Therapy · doi:10.22146/ijpther.3244 · Cited by 1
Majeed, T., Adnan, R., Mubshar, I., Mahmood, H., Saba, K., Imam, S. F., Zafar, M. A.-F., & Bukhari, M. H. (2015) · The Professional Medical Journal · doi:10.17957/tpmj/15.3019 · Cited by 2
The prophylactic role of metformin in obese pregnant woman
Alkhafajy, W. R., & Mubarak, A. R. (2024) · Salud Ciencia y Tecnología · doi:10.56294/saludcyt20251004 · Cited by 1
The Regulatory Effects of Pea Protein Hydrolysate on Lipid Metabolism in Gestational Diabetic Mice
Yu, T., Shang, N., Chen, L., Lü, K., Xia, H., Yang, L., Wang, S., Sun, G., & Liao, W. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70178 · Cited by 3
“To reach normal blood glucose levels, additional insulin therapy may be required [30].”
Metformina y gliburida en el tratamiento de la diabetes gestacional
de Santander, M. I. X. N. D. M. U. I., Hernández, A. A., Castillo, D. R., & de Santander, U. I. (2015) · Revista Médicas UIS · doi:10.18273/revmed.v28n3-2015008 · Cited by 5
Diabetes in Pregnancy: Worldwide Perspective
Lee, I., & Maple-Brown, L. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-90988-2_20 · Cited by 1
Nollino, L., Marcon, M. L., Kiwanuka, E., Cazziola-Merlotto, M., Sambataro, M. P., Sambado, L., Trevisiol, E., Scantamburlo, A., Mauri, A., Busato, E., et al. (2019) · Quality Management in Health Care · doi:10.1097/qmh.0000000000000202 · Cited by 2
Jain, R. K., Olejas, S., Goo, L. S., Bhavatharinin, N., Dengra, A. S., Shoghli, R., Davey, S., & Jain, R. (2019) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20190403.12 · Cited by 1
“Titre of Glibenclamide in umbilical cord plasma is around 70% of maternal levels and is therefore linked with the higher level of neo-born hypoglycaemia and LGA (macrosomia) if we compare with Metformin or Insulin in review (28).”
BackgroundInfluentialCONTROL PRECONCEPCIONAL Y DIABETES GESTACIONAL. REVISIÓN SISTEMÁTICA Y ESTADO DEL ARTE
García, R. J. H., Vásquez, V. H., & Vásquez, V. H. (2020) · Revista Biociencias · doi:10.18041/2390-0512/biociencias.1.6357 · Cited by 1
Pharmacotherapy of Gestational Diabetes Mellitus: Current Recommendations
Radenković, M., & Jakovljević, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100266 · Cited by 2
“When compared to women who were treated with insulin, women who were given metformin had a lower rate of preterm, neonatal jaundice, and admission to a neonatal unit, as well as an overall improvement in newborn morbidity [37].”
BackgroundMethodResultInfluentialCurrent treatment for gestational diabetes
Salat, D., & Aguilera, C. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.02.025 · Cited by 1
The Role of Organic Cation Transporter 3 in Metformin Disposition during Pregnancy
Lee, N. (2014) · ResearchWorks at the University of Washington (University of Washington)
Gortazar, L., Mañé, L., Chillarón, J. J., & Roux, J. A. F. (2017) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2017.02.009 · Cited by 2
Majeed, T., Adnan, R., Mubshar, I., Mahmood, H., Saba, K., Imam, S. F., Zafar, M. A.-F., & Bukhari, M. H. (2015) · The Professional Medical Journal · doi:10.29309/tpmj/2015.22.10.983
Metformin Vs Insulin for Treatment of Gestational Diabetes-A Randomized Clinical Trial
Pranathi, D. L., & Devi, D. V. R. (2018) · International Journal Of Medical Science And Clinical Invention · doi:10.18535/ijmsci/v5i1.15
Anesthesia for the Pregnant Diabetic Patient
Şalvız, E. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-93163-0_3
Novosti u liječenju gestacijskog dijabetesa
Hlača, N., & Majanović, S. K. (2019) · Medicina Fluminensis · doi:10.21860/medflum2019_227123
Metadata
- Authors
- Gui, J., Liu, Q., & Feng, L.
- Affiliations
- Tongji Hospital (CN)
- Corresponding author
- Feng, Ling
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-27
- Volume
- 8
- Issue
- 5
- Pages
- e64585
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3664585
- OpenAlex
- W2109810300
- Cited by
- 222
- References
- 37
- Citations by year
- 2026: 4 · 2025: 8 · 2024: 13 · 2023: 16 · 2022: 13 · 2021: 22 · 2020: 15 · 2019: 19 · 2018: 31 · 2017: 13 · 2016: 12 · 2015: 34 · 2014: 19 · 2013: 3
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- metformin, insulin, gestational diabetes mellitus, glycemic control, maternal outcomes, neonatal outcomes, preterm birth, gestational hypertension, gestational weight gain, fasting blood glucose, oral glucose tolerance test
- MeSH terms
- Birth Weight, Female, Humans, Hypoglycemic Agents, Infant, Newborn, Insulin, Metformin, Pregnancy, Pregnancy Outcome, Diabetes, Gestational, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.